• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Thursday

    5/26/22 12:15:27 PM ET
    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NRIX alert in real time by email

     

    On Thursday, 94 companies set new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • Medtronic (NYSE:MDT) was the biggest company on a market cap basis to set a new 52-week low.
    • Performance Shipping (NASDAQ:PSHG) was the smallest company when considering market cap to set a new 52-week low.
    • NRX Pharmaceuticals (NASDAQ:NRXP)'s stock came under the most pressure, trading down 63.34% to reach a new 52-week low.
    • Centogene (NASDAQ:CNTG)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    Stocks that set new 52-week lows on Thursday are as follows:

    • Medtronic (NYSE:MDT) stock drifted down 4.4% on Thursday morning to hit a new 52-week low of $98.18.
    • Snowflake (NYSE:SNOW) stock set a new 52-week low of $112.10 on Thursday, moving down 7.55%.
    • Datadog (NASDAQ:DDOG) shares reached a new 52-week low of $82.21 on Thursday morning, moving down 0.1%.
    • MongoDB (NASDAQ:MDB) stock dropped to a yearly low on Thursday of $213.70. Shares traded down 1.77%.
    • Amerco (NASDAQ:UHAL) shares set a new 52-week low of $481.02. The stock traded down 2.55%.
    • Endava (NYSE:DAVA) shares set a new yearly low of $86.17 this morning. The stock was up 3.63% on the session.
    • Nutanix (NASDAQ:NTNX) shares were down 26.52% for the day, having made a 52-week low of $13.51.
    • Super Group (SGHC) (NYSE:SGHC) stock drifted up 0.63% on Thursday morning to hit a new 52-week low of $6.01.
    • Manchester United (NYSE:MANU) stock achieved a new 52-week low on Thursday morning, hitting $10.51 and moving down 10.76%.
    • Jack In The Box (NASDAQ:JACK) shares fell to $65.00 on Thursday, setting a new 52-week low with a shift of down 2.79%.
    • Taro Pharmaceutical Indus (NYSE:TARO) stock set a new 52-week low of $33.59 on Thursday, moving down 6.0%.
    • Zuora (NYSE:ZUO) shares fell to $8.50 on Thursday, setting a new 52-week low with a shift of up 3.88%.
    • Marathon Digital Holdings (NASDAQ:MARA) shares set a new yearly low of $8.53 this morning. The stock was up 2.91% on the session.
    • Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved down 3.17% on Thursday to hit a new 52-week low of $16.02, drifting down 3.17%.
    • Columbus McKinnon (NASDAQ:CMCO) stock broke to a new 52-week low of $30.13 on Thursday. Shares of the company traded down 1.96%.
    • Morphic Holding (NASDAQ:MORF) shares made a new 52-week low of $21.10 on Thursday. The stock was up 4.74% for the day.
    • Riot Blockchain (NASDAQ:RIOT) stock achieved a new 52-week low on Thursday morning, hitting $5.97 and moving up 3.89%.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPB) shares fell to $9.55 on Thursday, setting a new 52-week low with a shift of up 5.05%.
    • TrueBlue (NYSE:TBI) shares hit a yearly low of $19.20. The stock was down 6.96% on the session.
    • RedBall Acquisition (NYSE:RBAC) shares set a new 52-week low of $8.86. The stock traded down 5.16%.
    • Merus (NASDAQ:MRUS) shares moved down 3.38% on Thursday to hit a new 52-week low of $13.92, drifting down 3.38%.
    • Haymaker Acquisition (NASDAQ:HYAC) shares hit a yearly low of $9.41. The stock was down 4.23% on the session.
    • Stoke Therapeutics (NASDAQ:STOK) shares made a new 52-week low of $11.64 on Thursday. The stock was down 1.16% for the day.
    • Hut 8 Mining (NASDAQ:HUT) stock hit a new 52-week low of $2.10. The stock was up 2.9% on the session.
    • Albireo Pharma (NASDAQ:ALBO) stock achieved a new 52-week low on Thursday morning, hitting $19.87 and moving up 0.94%.
    • Nurix Therapeutics (NASDAQ:NRIX) stock achieved a new 52-week low on Thursday morning, hitting $7.52 and moving down 21.98%.
    • Monte Rosa Therapeutics (NASDAQ:GLUE) shares made a new 52-week low of $7.19 on Thursday. The stock was up 1.94% for the day.
    • Bitfarms (NASDAQ:BITF) stock broke to a new 52-week low of $1.61 on Thursday. Shares of the company traded up 2.98%.
    • Heron Therapeutics (NASDAQ:HRTX) shares made a new 52-week low of $3.05 on Thursday. The stock was up 4.68% for the day.
    • Latch (NASDAQ:LTCH) stock achieved a new 52-week low on Thursday morning, hitting $2.01 and moving up 7.28%.
    • NextNav (NASDAQ:NN) stock dropped to a yearly low on Thursday of $3.08. Shares traded down 3.06%.
    • OraSure Technologies (NASDAQ:OSUR) stock hit a yearly low of $4.00. The stock was down 2.77% for the day.
    • Avaya Hldgs (NYSE:AVYA) shares hit a yearly low of $2.93. The stock was up 4.81% on the session.
    • Veritone (NASDAQ:VERI) stock drifted up 3.67% on Thursday morning to hit a new 52-week low of $7.14.
    • Aerie Pharmaceuticals (NASDAQ:AERI) stock hit a new 52-week low of $5.33. The stock was up 0.91% on the session.
    • Biotech Acquisition (NASDAQ:BIOT) shares moved down 9.73% on Thursday to hit a new 52-week low of $8.30, drifting down 9.73%.
    • Ocular Therapeutix (NASDAQ:OCUL) stock dropped to a yearly low on Thursday of $2.95. Shares traded down 1.47%.
    • Macrogenics (NASDAQ:MGNX) stock drifted down 0.28% on Thursday morning to hit a new 52-week low of $3.48.
    • Cryptyde (NASDAQ:TYDEV) shares set a new 52-week low of $10.70. The stock traded down 20.74%.
    • Jounce Therapeutics (NASDAQ:JNCE) shares set a new 52-week low of $3.73. The stock traded up 0.26%.
    • Alpha Teknova (NASDAQ:TKNO) shares moved up 2.33% on Thursday to hit a new 52-week low of $6.38, drifting up 2.33%.
    • Accuray (NASDAQ:ARAY) stock drifted up 0.99% on Thursday morning to hit a new 52-week low of $2.00.
    • Fusion Pharmaceuticals (NASDAQ:FUSN) stock drifted down 0.93% on Thursday morning to hit a new 52-week low of $3.70.
    • Yiren Digital (NYSE:YRD) shares made a new 52-week low of $1.56 on Thursday. The stock was down 7.23% for the day.
    • Zepp Health (NYSE:ZEPP) shares made a new 52-week low of $1.99 on Thursday. The stock was up 3.47% for the day.
    • Ovid Therapeutics (NASDAQ:OVID) stock set a new 52-week low of $1.78 on Thursday, moving down 3.26%.
    • OFS Credit (NASDAQ:OCCI) shares were up 1.08% for the day, having made a 52-week low of $10.01.
    • Shattuck Labs (NASDAQ:STTK) stock hit a yearly low of $2.59. The stock was up 0.18% for the day.
    • CytomX Therapeutics (NASDAQ:CTMX) stock drifted up 0.98% on Thursday morning to hit a new 52-week low of $1.50.
    • Exela Technologies (NASDAQ:XELA) shares were up 0.05% for the day, having made a 52-week low of $0.21.
    • Avadel Pharmaceuticals (NASDAQ:AVDL) shares hit a yearly low of $1.57. The stock was down 52.96% on the session.
    • AstroNova (NASDAQ:ALOT) stock achieved a new 52-week low on Thursday morning, hitting $11.79 and moving down 1.96%.
    • TCR2 Therapeutics (NASDAQ:TCRR) shares set a new 52-week low of $2.06. The stock traded up 1.42%.
    • Akumin (NASDAQ:AKU) stock set a new 52-week low of $0.84 on Thursday, moving down 2.26%.
    • Quanergy Systems (NYSE:QNGY) stock drifted up 0.49% on Thursday morning to hit a new 52-week low of $0.78.
    • Comera Life Sciences (NASDAQ:CMRA) stock set a new 52-week low of $4.22 on Thursday, moving down 15.33%.
    • Centogene (NASDAQ:CNTG) stock dropped to a yearly low on Thursday of $2.59. Shares traded 0.0% (flat).
    • Visionary Education Tech (NASDAQ:VEDU) stock hit a new 52-week low of $1.35. The stock was up 7.24% on the session.
    • Rain Therapeutics (NASDAQ:RAIN) shares set a new 52-week low of $2.17. The stock traded up 1.81%.
    • Verrica Pharmaceuticals (NASDAQ:VRCA) stock broke to a new 52-week low of $1.80 on Thursday. Shares of the company traded up 0.05%.
    • Molecular Templates (NASDAQ:MTEM) stock dropped to a yearly low on Thursday of $0.94. Shares traded down 5.83%.
    • Ocean Power Technologies (AMEX:OPTT) shares moved down 4.23% on Thursday to hit a new 52-week low of $0.89, drifting down 4.23%.
    • Charles & Colvard (NASDAQ:CTHR) stock achieved a new 52-week low on Thursday morning, hitting $1.32 and moving up 0.75%.
    • Societal CDMO (NASDAQ:SCTL) shares reached a new 52-week low of $0.71 on Thursday morning, moving down 1.2%.
    • Spero Therapeutics (NASDAQ:SPRO) shares moved down 0.42% on Thursday to hit a new 52-week low of $1.17, drifting down 0.42%.
    • PhaseBio Pharmaceuticals (NASDAQ:PHAS) stock broke to a new 52-week low of $0.74 on Thursday. Shares of the company traded up 3.54%.
    • Tenon Medical (NASDAQ:TNON) stock hit a yearly low of $3.05. The stock was up 1.59% for the day.
    • Kala Pharmaceuticals (NASDAQ:KALA) stock achieved a new 52-week low on Thursday morning, hitting $0.37 and moving down 5.0%.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) stock achieved a new 52-week low on Thursday morning, hitting $1.64 and moving down 1.15%.
    • Firsthand Tech Value Fund (NASDAQ:SVVC) shares set a new 52-week low of $2.70. The stock traded down 1.84%.
    • Clarus Therapeutics Hldgs (NASDAQ:CRXT) shares made a new 52-week low of $0.33 on Thursday. The stock was up 3.83% for the day.
    • Pasithea Therapeutics (NASDAQ:KTTA) stock drifted down 0.4% on Thursday morning to hit a new 52-week low of $0.81.
    • Locafy (NASDAQ:LCFY) shares hit a yearly low of $0.80. The stock was up 4.27% on the session.
    • Shineco (NASDAQ:SISI) shares set a new 52-week low of $1.61. The stock traded down 1.2%.
    • Advanced Human Imaging (NASDAQ:AHI) shares fell to $0.67 on Thursday, setting a new 52-week low with a shift of down 5.84%.
    • Secoo Holding (NASDAQ:SECO) shares set a new yearly low of $0.22 this morning. The stock was down 4.76% on the session.
    • BIO-key Intl (NASDAQ:BKYI) stock set a new 52-week low of $1.76 on Thursday, moving down 3.03%.
    • Windtree Therapeutics (NASDAQ:WINT) stock broke to a new 52-week low of $0.45 on Thursday. Shares of the company traded up 3.06%.
    • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares were down 0.83% for the day, having made a 52-week low of $1.14.
    • INVO Bioscience (NASDAQ:INVO) stock set a new 52-week low of $0.85 on Thursday, moving down 3.17%.
    • JX Luxventure (NASDAQ:LLL) shares reached a new 52-week low of $1.28 on Thursday morning, moving down 3.57%.
    • Blue Hat Interactive (NASDAQ:BHAT) stock hit $0.15 on Thursday morning, setting a new 52-week low for a change of down 14.72%.
    • Viveve Medical (NASDAQ:VIVE) stock drifted up 3.86% on Thursday morning to hit a new 52-week low of $0.72.
    • AutoWeb (NASDAQ:AUTO) shares hit a yearly low of $0.49. The stock was up 1.57% on the session.
    • Acorda Therapeutics (NASDAQ:ACOR) stock broke to a new 52-week low of $0.40 on Thursday. Shares of the company traded up 1.22%.
    • Performance Shipping (NASDAQ:PSHG) stock drifted down 4.16% on Thursday morning to hit a new 52-week low of $1.80.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $NRIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NRIX
    $NRXP
    $NTNX
    $OCCI

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Medtronic plc.
    $MDT
    2/9/2026$121.00Hold → Buy
    Needham
    Stoke Therapeutics Inc.
    $STOK
    2/5/2026$60.00Buy
    Guggenheim
    Medtronic plc.
    $MDT
    2/3/2026$117.00Buy
    Citigroup
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Medtronic plc.
    $MDT
    1/30/2026$114.00Overweight
    Wells Fargo
    Datadog Inc.
    $DDOG
    1/29/2026$215.00 → $170.00Outperform
    BMO Capital Markets
    Shattuck Labs Inc.
    $STTK
    1/28/2026$15.00Overweight
    Piper Sandler
    More analyst ratings

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Khan Salman Hassan covered exercise/tax liability with 31,007 shares, decreasing direct ownership by 3% to 1,104,359 units (SEC Form 4)

    4 - MARA Holdings, Inc. (0001507605) (Issuer)

    2/6/26 9:30:00 PM ET
    $MARA
    EDP Services
    Technology

    Chief Executive Officer Thiel Frederick G covered exercise/tax liability with 67,704 shares, decreasing direct ownership by 2% to 3,409,366 units (SEC Form 4)

    4 - MARA Holdings, Inc. (0001507605) (Issuer)

    2/6/26 9:30:01 PM ET
    $MARA
    EDP Services
    Technology

    General Counsel Nowaid Zabi covered exercise/tax liability with 14,249 shares, decreasing direct ownership by 2% to 690,985 units (SEC Form 4)

    4 - MARA Holdings, Inc. (0001507605) (Issuer)

    2/6/26 9:29:58 PM ET
    $MARA
    EDP Services
    Technology

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Egan-Jones Recommends Withhold Votes on Jack in the Box Directors Following -76% Shareholder Return

    Egan-Jones Proxy Services recommends that shareholders of Jack in the Box Inc. (NASDAQ:JACK) withhold votes from Chairman David Goebel and directors Guillermo Diaz, Jr., Madeleine Kleiner, Michael Murphy, James Myers, and Vivien Yeung, citing severe and sustained shareholder value destruction and continued operational deterioration. Over the past two years, Jack in the Box has delivered a -76% total shareholder return, significantly underperforming both its peer group and the broader market. Egan-Jones believes this performance reflects persistent governance failures, weak strategic execution, and ineffective oversight during a period of declining fundamentals. Jack in the Box's challen

    2/9/26 9:00:00 AM ET
    $JACK
    Restaurants
    Consumer Discretionary

    Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

    WEST CHESTER, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica") (NASDAQ:VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced the launch of YCANTH® in Japan by its partner, Torii Pharmaceutical Co. Ltd. ("Torii"), a wholly-owned subsidiary of Shionogi & Co., Ltd., for the treatment of molluscum contagiosum ("molluscum"). "We would like to congratulate our partner, Torii, on the launch of YCANTH in Japan for the treatment of molluscum. Torii's achievement also represents an exciting milestone for Verrica, as we continue to execute on our long-term strategy of developing a

    2/9/26 8:00:00 AM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nexus Global Payments Appoints Technical Operator

    PayNet and NETS joint venture awarded contract to be Nexus Technical Operator, with support from Endava and AWS Nexus Global Payments (NGP) appoints Payments Network Malaysia (PayNet) and Network for Electronic Transfers Singapore (NETS) joint venture as the Nexus Technical Operator (NTO). This follows a competitive procurement process involving global bidders and marks a major milestone in building an interoperable global payments infrastructure. The evaluation of bidders considered technical capability, operational resilience, cost efficiency, and alignment with Nexus' vision for global interoperability. PayNet and NETS joint venture emerged as the preferred partner due to the proven

    2/9/26 6:21:00 AM ET
    $DAVA
    EDP Services
    Technology

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Veritone Inc.

    SCHEDULE 13G/A - Veritone, Inc. (0001615165) (Subject)

    2/6/26 6:30:31 PM ET
    $VERI
    EDP Services
    Technology

    SEC Form 6-K filed by Bitfarms Ltd.

    6-K - Bitfarms Ltd (0001812477) (Filer)

    2/6/26 5:08:22 PM ET
    $BITF
    Finance: Consumer Services
    Finance

    SEC Form S-8 filed by Ocean Power Technologies Inc.

    S-8 - Ocean Power Technologies, Inc. (0001378140) (Filer)

    2/6/26 4:18:33 PM ET
    $OPTT
    Electric Utilities: Central
    Utilities

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Genmab A/S bought $79,098,068 worth of shares (815,444 units at $97.00) (SEC Form 4)

    4 - Merus N.V. (0001651311) (Issuer)

    12/29/25 5:16:48 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Genmab A/S bought $27,008,777 worth of shares (278,441 units at $97.00) (SEC Form 4)

    4 - Merus N.V. (0001651311) (Issuer)

    12/22/25 5:15:45 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Genmab A/S bought $26,340,059 worth of shares (271,547 units at $97.00) (SEC Form 4)

    4 - Merus N.V. (0001651311) (Issuer)

    12/18/25 5:54:51 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on MARA Holdings Inc. with a new price target

    Morgan Stanley initiated coverage of MARA Holdings Inc. with a rating of Underweight and set a new price target of $8.00

    2/9/26 7:01:42 AM ET
    $MARA
    EDP Services
    Technology

    Medtronic upgraded by Needham with a new price target

    Needham upgraded Medtronic from Hold to Buy and set a new price target of $121.00

    2/9/26 6:45:10 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Guggenheim initiated coverage on Stoke Therapeutics with a new price target

    Guggenheim initiated coverage of Stoke Therapeutics with a rating of Buy and set a new price target of $60.00

    2/5/26 6:58:02 AM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Financials

    Live finance-specific insights

    View All

    Endava to Announce Q2 FY2026 Financial Results on February 19, 2026

    Endava plc (NYSE:DAVA), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced it will release results for the second quarter ended December 31, 2025, on Thursday February 19, 2026 before the opening of regular U.S. market hours. Following the release, John Cotterell, Endava's CEO and Mark Thurston, Endava's CFO, will discuss the results in a conference call beginning at 8:00 am ET. Conference call access information is: Participant Toll Free Dial-In Number: 1-844-481-2736 Participant International Dial-In Number: 1-412-317-0665 Conference ID: Endava Call Webcast: https://investors.e

    2/5/26 4:22:00 PM ET
    $DAVA
    EDP Services
    Technology

    Nutanix Announces Date and Conference Call Information for Second Quarter Fiscal Year 2026 Financial Results

    SAN JOSE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ:NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second quarter of fiscal year 2026, which ended January 31, 2026, after U.S. markets close on Wednesday, February 25, 2026. Nutanix will host a conference call and earnings webcast beginning at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day to discuss the company's financial results. Interested parties may access the conference call by registering at this link to receive dial in details and a unique PIN number. The conference call will also be webcast live on the Nutanix Investor Relatio

    2/5/26 4:05:00 PM ET
    $NTNX
    Computer Software: Prepackaged Software
    Technology

    Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, following the close of market. Teknova will host a webcast and conference call on Thursday, February 26, 2026, beginning at 5:30 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this l

    2/5/26 4:01:00 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Leadership Updates

    Live Leadership Updates

    View All

    Nexus Global Payments Appoints Technical Operator

    PayNet and NETS joint venture awarded contract to be Nexus Technical Operator, with support from Endava and AWS Nexus Global Payments (NGP) appoints Payments Network Malaysia (PayNet) and Network for Electronic Transfers Singapore (NETS) joint venture as the Nexus Technical Operator (NTO). This follows a competitive procurement process involving global bidders and marks a major milestone in building an interoperable global payments infrastructure. The evaluation of bidders considered technical capability, operational resilience, cost efficiency, and alignment with Nexus' vision for global interoperability. PayNet and NETS joint venture emerged as the preferred partner due to the proven

    2/9/26 6:21:00 AM ET
    $DAVA
    EDP Services
    Technology

    Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development

    SAN DIEGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced a leadership transition designed to support the Company's next phase of growth and advancement toward late-stage development and key clinical and corporate milestones. Mani Mohindru, PhD, a member of Cardiff Oncology's Board of Directors since 2021 and a seasoned biotech executive, has been appointed interim Chief Executive Officer, effective immediately. Mark Erlander, PhD, Chief Executive Officer, and James Levine, Chief Financial Officer, have stepped down from their res

    1/27/26 7:00:00 AM ET
    $CRDF
    $CTMX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

    Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA® while at Regeneron Most recently served as Chief Marketing Officer, Global Ophthalmology at Merck BEDFORD, Mass., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that David W. Robinson has agreed to join the Company as Global Chief Commercial Officer. The appointment of Mr. Robinson, a proven commercial leader with a history of launching category-defining therapies, strategically positions Ocular for success

    1/21/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NRIX
    $NRXP
    $NTNX
    $OCCI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Latch Inc.

    SC 13G - Latch, Inc. (0001826000) (Subject)

    12/13/24 9:45:09 PM ET
    $LTCH
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Verrica Pharmaceuticals Inc.

    SC 13G/A - Verrica Pharmaceuticals Inc. (0001660334) (Subject)

    12/9/24 6:22:49 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Shattuck Labs Inc.

    SC 13D/A - Shattuck Labs, Inc. (0001680367) (Subject)

    12/6/24 9:03:38 PM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care